Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Aptabio Therapeutics, Inc.

Clinical trials sponsored by Aptabio Therapeutics, Inc., explained in plain language.

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

New drug aims to shield kidneys from dye damage during heart surgery

Disease control Ongoing

This study tests whether the drug APX-115 can prevent kidney injury caused by contrast dye used in heart procedures. About 230 adults with kidney disease will receive either the drug or a placebo before and after their procedure. The goal is to see if the drug reduces kidney dama…

Phase: PHASE2 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC